From local to global - Fifty years of research on Salvia divinorum

Journal of Ethnopharmacology

Volumn 151, Issue 2, 2014, Pages 768-783

  Casselman, Ivan ^a   Nock, Catherine J ^a   Wohlmuth, Hans ^a   Weatherby, Robert P ^a   Heinrich, Michael ^a,b,c  

^a SOUTHERN CROSS UNIVERSITY   (Australia)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

2.136: Botany; 2.232: Diterpenoids; 2.312: Hallucinogenic

Indexed keywords

DITERPENE; DITERPENOID; SALVINORIN A; TRITERPENE;

ANTIDEPRESSANT ACTIVITY; ANTINOCICEPTION; AREA UNDER THE CURVE; DRUG BINDING; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG SYNTHESIS; ETHNOBOTANY; ETHNOPHARMACOLOGY; GERMINATION; HUMAN; MEDICAL RESEARCH; NONHUMAN; PHYLOGENY; PLANT GENETICS; PLANT TAXONOMY; POLLINATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SALVIA DIVINORUM; SEARCH ENGINE; THERAPY EFFECT; TOXICOLOGY; TRANQUILIZING ACTIVITY;

ANIMALIA; SALVIA DIVINORUM;

2.136: BOTANY; 2.232: DITERPENOIDS; 2.312: HALLUCINOGENIC;

ANIMALS; DITERPENES, CLERODANE; ETHNOPHARMACOLOGY; HUMANS; MEDICINE, TRADITIONAL; MEXICO; PSYCHOTROPIC DRUGS; RESEARCH; SALVIA;

EID: 84895073829     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2013.11.032     Document Type: Review

References (149)

1. P.H. Addy Acute and post-acute behavioural and psychological effects of salvinorin A in humans Psychopharmacology 220 2012 195 204
2. N. Adham, J.A. Tamm, J.A. Salon, P.J. Vaysse, R.L. Weinshank, and T.A. Branchek A single point mutation increases the affinity of serotonin 5-HT1D [alpha], 5-HT1D [beta], 5-HT1E and 5-HT1F receptors for [beta]-adrenergic antagonists Neuropharmacology 33 1994 387 391
3. J.W. Allen Chasing the ghost of Maria Sabina, saint mother of the sacred mushroom Psychedelic Illuminations 6 1994
4. J.W. Allen Maria Sabina, Saint Mother of the Sacred Mushroom: Ethnomycological Journals Sacred Mushrooms Studies 1997 Psilly Publications/Raver-Books
5. M.A. Ansonoff, J. Zhang, T. Czyzyk, R.B. Rothman, J. Stewart, H. Xu, J. Zjwiony, D.J. Siebert, F. Yang, and B.L. Roth Antinociceptive and hypothermic effects of salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice J. Pharmacol. Exp. Ther. 318 2006 641
6. J. Appel, and D. Kim-Appel The rise of a new psychoactive agent: Salvia divinorum Int. J. Ment. Health Addict. 5 2007 248 253
7. M. Atanassova, S. Georgieva, and K. Ivancheva Total phenolic and total flavonoid contents, antioxidant capacity and biological contaminants in medicinal herbs J. Univ. Chem. Technol. Metall. 46 2011 81 88
8. G. Aviello, F. Borrelli, F. Guida, B. Romano, K. Lewellyn, M. De Chiaro, L. Luongo, J.K. Zjawiony, S. Maione, A.A. Izzo, and R. Capasso Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo J. Mol. Med. 89 2011 891 902
9. L.E. Baker, J.J. Panos, B.A. Killinger, M.M. Peet, L.M. Bell, L.A. Haliw, and S.L. Walker Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats Psychopharmacology 203 2009 203 211
10. B.M.R. Bandara, W.R. Wimalasiri, W.A. Wickremasinghe, and K. Bandara Cyperenoic acid and (-)-hardwickiic acid from the chloroform extract of the roots of Croton aromaticus: isolation and insecticidal properties J. Nat. Sci. Counc. Sri Lanka 18 1990 119 126
11. B.R. Bandara, W.R. Wimalasiri, and K.P. Bandara Isolation and insecticidal activity of (-)-hardwickiic acid from Croton aromaticus Planta Med. 53 1987 575
12. P. Beerepoot, V. Lam, A. Luu, B. Tsoi, D. Siebert, and H. Szechtman Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole Neurosci. Lett. 446 2008 101 104
13. Beifuss, W.; 1997. Cultivating Diviner's Sage: A Step by Step Guide to Cultivation, Propagation, and Keeping your Salvia Plants Happy. The Resonance Project 1.
14. G. Bentham Labiatae, in: Genera Plantarum 1876 Reeve & Co. London
15. C.M. Bertea, P. Luciano, S. Bossi, F. Leoni, C. Baiocchi, C. Medana, C.M. Azzolin, G. Temporale, M.A. Lombardozzi, and M.E. Maffei PCR and PCR-RFLP of the 5S-rRNA-NTS region and salvinorin A analyses for the rapid and unequivocal determination of Salvia divinorum Phytochemistry 67 2006 371 378
16. A.K. Bigham, T.A. Munro, M.A. Rizzacasa, and R.M. Robins-Browne Divinatorins A-C, new neoclerodane diterpenoids from the controlled sage Salvia divinorum J. Nat. Prod. 66 2003 1242 1244
17. M.C. Bonito, C. Cicala, M.C. Marcotullio, F. Maione, and N. Mascolo Biological activity of bicyclic and tricyclic diterpenoids from Salvia species of immediate pharmacological and pharmaceutical interest Nat. Prod. Commun. 6 2011 1205 1215
18. D. Braida, V. Capurro, A. Zani, T. Rubino, D. Viganò, D. Parolaro, and M. Sala Potential anxiolyticand antidepressantlike effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents Br. J. Pharmacol. 157 2009 844 853
19. D. Braida, A. Donzelli, R. Martucci, V. Capurro, and M. Sala Learning and memory impairment induced by salvinorin A, the principal ingredient of Salvia divinorum, in wistar rats Int. J. Toxicol. 30 2011 650 661
20. D. Braida, V. Limonta, V. Capurro, P. Fadda, T. Rubino, P. Mascia, A. Zani, E. Gori, W. Fratta, D. Parolaro, and M. Sala Involvement of κ-opioid and endocannabinoid system on Salvinorin A-induced reward Biol. Psychiatry 63 2008 286 292
21. D. Braida, V. Limonta, S. Pegorini, A. Zani, C. Guerini-Rocco, E. Gori, and M. Sala Hallucinatory and rewarding effect of salvinorin A in zebrafish: κ-opioid and CB1-cannabinoid receptor involvement Psychopharmacology 190 2007 441 448
22. E.R. Butelman, M. Caspers, K.M. Lovell, M.J. Kreek, and T.E. Prisinzano Behavioural effects and central nervous system levels of the broadly available κ-agonist hallucinogen salvinorin A are affected by P-glycoprotein modulation in vivo J. Pharmacol. Exp. Ther. 341 2012 802 808
23. E.R. Butelman, T.J. Harris, and M.J. Kreek The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys Psychopharmacology 172 2004 220 224
24. E.R. Butelman, M. Mandau, K. Tidgewell, T.E. Prisinzano, V. Yuferov, and M.J. Kreek Effects of salvinorin A, a κ-opioid hallucinogen, on a neuroendocrine biomarker assay in nonhuman primates with high κ-receptor homology to humans J. Pharmacol. Exp. Ther. 320 2007 300 306
25. E.R. Butelman, T.E. Prisinzano, H. Deng, S. Rus, and M.J. Kreek Unconditioned behavioural effects of the powerful κ-opioid hallucinogen salvinorin A in nonhuman primates: fast onset and entry into cerebrospinal fluid J. Pharmacol. Exp. Ther. 328 2009 588
26. R. Campbell The Resonance Project 1 1997 Sage Wisdom 27 31
27. R. Capasso, F. Borrelli, F. Capasso, D.J. Siebert, D.J. Stewart, J.K. Zjawiony, and A.A. Izzo The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guineapig ileum Neurogastroenterol. Motility 18 2006 69 75
28. R. Capasso, F. Borrelli, M.G. Cascio, G. Aviello, K. Huben, J.K. Zjawiony, P. Marini, B. Romano, V. Di Marzo, F. Capasso, and A.A. Izzo Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between κ-opioid and cannabinoid CB1 receptors Br. J. Pharmacol. 155 2008 681 689
29. R. Capasso, F. Borrelli, J. Zjawiony, L. Kutrzeba, G. Aviello, G. Sarnelli, F. Capasso, and A.A. Izzo The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice Neurogastroenterol. Motility 20 2008 142 148
30. W.A. Carlezon Jr, C. Béguin, J.A. DiNieri, M.H. Baumann, M.R. Richards, M.S. Todtenkopf, R.B. Rothman, Z. Ma, Y.W. David, and B.M. Cohen Depressive-like effects of the κ-opioid receptor agonist salvinorin A on behaviour and neurochemistry in rats J. Pharmacol. Exp. Ther. 316 2006 440 447
31. I. Casselman, and M. Heinrich Novel use patterns of Salvia divinorum: unobtrusive observation using YouTube J. Ethnopharmacol. 138 2011 227 662
32. 27OCOOH Z. Kristallogr.: New Cryst. Struct. 219 2004 111 113
33. C. Chavkin, S. Sud, W. Jin, J. Stewart, J.K. Zjawiony, D.J. Siebert, B.A. Toth, S.J. Hufeisen, and B.L. Roth Salvinorin A, an active component of the hallucinogenic sage Salvia divinorum is a highly efficacious κ-opioid receptor agonist: structural and functional considerations J. Pharmacol. Exp. Ther. 308 2004 1197 1203
34. Comisión Nacional para el Desarrollo de los Pueblos Indígenas. México [WWW Document], 2013. URL http://www.cdi.gob.mx/ index.php?id-seccion=660a (accessed 9.2.13).
35. J. Diaz Salvia divinorum: a psychopharmacological riddle and a mind-body prospect Curr. Drug Abuse Rev. 6 2013 43 53
36. J.L. Diaz Ethnopharmacology and taxonomy of Mexican psychodysleptic plants J. Psychedelic Drugs 11 1979 71 101
37. Epling, C.; Jativa, C.D.; 1962. A New Species of Salvia from Mexico. Botanical Museum Leaflets, Harvard University 20, 297-299.
38. A. Estrada La Vida de Maria Sabina: La Sabia de los Hongos 1977 Ross-Erikson Mexico
39. W.E. Fantegrossi, K.M. Kugle, L.J. Valdés, M. Koreeda, and J.H. Woods Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse Behav. Pharmacol. 16 2005 627
40. J. Fichna, M. Dicay, S.A. Hirota, D. Traboulsi, J.A. Macdonald, A. Janecka, P.L. Beck, J.K. Zjawiony, W.K. Macnaughton, and M.A. Storr Differential effects of salvinorin A on endotoxin-induced hypermotility and neurogenic ion transport in mouse ileum Neurogastroenterol. Motility 23 2011 e212 e583
41. J. Fichna, R. Schicho, C.N. Andrews, M. Bashashati, M. Klompus, D.M. McKay, K.A. Sharkey, J.K. Zjawiony, A. Janecka, and M.A. Storr Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating κ-opioid and cannabinoid receptors Neurogastroenterol. Motility 21 2009 (1326-1334+e127-e128)
42. Jakub Fichna, R. Schicho, A. Janecka, J.K. Zjawiony, and M. Storr Selective natural κ opioid and cannabinoid receptor agonists with a potential role in the treatment of gastrointestinal dysfunction-Analogues of salvinorin A, an active ingredient in Salvia divinorum, provide an attractive target as future therapeutics in human gastrointestinal dysfunctions Drug News Perspect. 22 2009 383
43. P.G. Fine, and R.K. Portenoy Chapter 2: The Endogenous Opioid System. A Clinical Guide to Opioid Analgesia 2004 McGraw Hill
44. S. Foster Herbal Bounty! The Gentle Art of Herb Culture 1984 Gibbs Smith
45. B.J. Gehrke, V.I. Chefer, and T.S. Shippenberg Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum Psychopharmacology 197 2008 509 517
46. S. Gibbons "Legal Highs" novel and emerging psychoactive drugs: a chemical overview for the toxicologist Clin. Toxicol. 50 2012 15 24
47. P. Giovannini, and M. Heinrich Xki yoma' (our medicine) and xki tienda (patent medicine). interface between traditional and modern medicine among the Mazatecs of Oaxaca, Mexico J. Ethnopharmacol. 121 2009 383 399
48. C. Giroud, F. Felber, M. Augsburger, B. Horisberger, L. Rivier, and P. Mangin Salvia divinorum: an hallucinogenic mint which might become a new recreational drug in Switzerland Forensic Sci. Int. 112 2000 143 150
49. R.J. Grayer, M.R. Eckert, N.C. Veitch, G.C. Kite, P.D. Marin, T. Kokubun, M.S. Simmonds, and A.J. Paton The chemotaxonomic significance of two bioactive caffeic acid esters, nepetoidins A and B, in the Lamiaceae Phytochemistry 64 2003 519 528
50. M. Grilli, E. Neri, S. Zappettini, F. Massa, A. Bisio, G. Romussi, M. Marchi, and A. Pittaluga Salvinorin A exerts opposite presynaptic controls on neurotransmitter exocytosis from mouse brain nerve terminals Neuropharmacology 57 2009 523 530
51. O. Grundmann, S.M. Phipps, I. Zadezensky, and V. Butterweck Salvia divinorum and salvinorin A: an update on pharmacology and analytical methodology Planta Med. Nat. Prod. Med. Plant Res. 73 2007 1039 1046
52. F. Guida, L. Luongo, G. Aviello, E. Palazzo, M. De Chiaro, L. Gatta, S. Boccella, I. Marabese, J.K. Zjawiony, R. Capasso, A.A. Izzo, V. de Novellis, and S. Maione Salvinorin A reduces mechanical allodynia and spinal neuronal hyperexcitability induced by peripheral formalin injection Mol. Pain 8 1 2012 60
53. J.R. Hanson Natural products from the hallucinogenic sage Sci. Prog. 93 2010 171 180
54. M.T. Harden, S.E. Smith, J.A. Niehoff, C.R. McCurdy, and G.T. Taylor Antidepressive effects of the κ-opioid receptor agonist salvinorin A in a rat model of anhedonia Behav. Pharmacol. 23 2012 710 715
55. W.W. Harding, K. Tidgewell, M. Schmidt, K. Shah, C.M. Dersch, J. Snyder, D. Parrish, J.R. Deschamps, R.B. Rothman, and T.E. Prisinzano Salvinicins A and B, new neoclerodane diterpenes from Salvia divinorum Org. Lett. 7 2005 3017 3020
56. C. Hine Virtual ethnography: modes, varieties, affordances N. Fielding, R.M. Lee, G. Blank, The SAGE Handbook of Online Research Methods 0 2008 Sage Publications Inc. Los Angeles 257
57. A. Hofmann LSD: My Problem Child 1980 McGraw-Hil 209
58. A. Hofmann Ride through the Sierra Mazateca in search of the magic plant "Ska Maria Pastora" T.J. Riedlinger, The Sacred Mushrooms Seeker: Essays for R. Gordon Wasson 1990 Dioscorides Press/Timber Press 115 127
59. J.M. Hooker, Y. Xu, W. Schiffer, C. Shea, P. Carter, and J.S. Fowler Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans Neuroimage 41 2008 1044 1050
60. V. Hoover, D.B. Marlowe, N.S. Patapis, D.S. Festinger, and R.F. Forman Internet access to Salvia divinorum: implications for policy, prevention, and treatment J. Subst. Abuse Treat. 35 2008 22 27
61. I.F. James, C. Chavkin, and A. Goldstein Selectivity of dynorphin for [kappa] opioid receptors Life Sci. 31 1982 1331 1334
62. A.A. Jenks, and S.-C. Kim Medicinal plant complexes of Salvia subgenus Calosphace: an ethnobotanical study of new world sages J. Ethnopharmacol. 146 2013 214 224
63. A.A. Jenks, J.B. Walker, and S.-C. Kim Evolution and origins of the Mazatec hallucinogenic sage, Salvia divinorum (Lamiaceae): a molecular phylogenetic approach J. Plant Res 2010
64. A.A. Jenks, J.B. Walker, and S.-C. Kim Evolution and origins of the Mazatec hallucinogenic sage, Salvia divinorum (Lamiaceae): a molecular phylogenetic approach J. Plant Res. 124 2011 593 600
65. T.F. John, L.G. French, and J.S. Erlichman The antinociceptive effect of salvinorin A in mice Eur. J. Pharmacol. 545 2006 129 133
66. Johnson, 1939. The Elements of Mazatec Witchcraft. Goteborgs Etnografiska Museum Etnologiska Studier 9 119-149.
67. MacLean Johnson, K.A. Reissig, C.J. Prisinzano, and T.E. Griffiths, R.R. Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum Drug Alcohol Depend. 115 2011 150 155
68. B.C. Kelly Legally tripping: a qualitative profile of Salvia divinorum use among young adults J. Psychoact. Drugs 43 2011 46 54
69. B.A. Killinger, M.M. Peet, and L.E. Baker Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague-Dawley rats Pharmacol. Biochem. Behav. 96 2010 260 265
70. A. Kowalczuk, V. Raman, A. Galal, I. Khan, D. Siebert, and J. Zjawiony Vegetative anatomy and micromorphology of Salvia divinorum (Lamiaceae) from Mexico, combined with chromatographic analysis of salvinorin A J. Nat. Med. 2013 1 11
71. Kutrzeba, F.E. Dayan, J.L. Howell, J. Feng, J.L. Giner, and J.K. Zjawiony Biosynthesis of salvinorin A proceeds via the deoxyxylulose phosphate pathway Phytochemistry 68 2007 1872 1881
72. Kutrzeba, D. Ferreira, and J.K. Zjawiony Salvinorins J from Salvia divinorum: mutarotation in the neoclerodane system J. Nat. Prod. 72 2009 1361 1363
73. Kutrzeba, V.T. Karamyan, R.C. Speth, J.S. Williamson, and J.K. Zjawiony In vitro studies on metabolism of salvinorin A Pharm. Biol. 47 2009 1078 1084
74. D.Y. Lee, Z. Ma, L.Y. Liu-Chen, Y. Wang, Y. Chen, W.A. Carlezon Jr, and B. Cohen New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human [kappa] opioid receptors Bioorg. Med. Chem. 13 2005 5635 5639
75. A. Lozama, and T.E. Prisinzano Chemical methods for the synthesis and modification of neoclerodane diterpenes Bioorg. Med. Chem. Lett. 19 2009 5490 5495
76. D.J. Mabberley Mabberley's Plant-book: A Portable Dictionary of Plants, their Classification and Uses 2008 Cambridge University Press
77. K. MacLean, M. Johnson, C. Reissig, T. Prisinzano, and R. Griffiths Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects Psychopharmacology 226 2013 381 392
78. J.D. McChesney, A.M. Clark, and E.R. Silveira Antimicrobial diterpenes of Croton sonderianus, 1. Hardwickic and 3,4-secotrachylobanoic acids J. Nat. Prod. 54 1991 1625 1633
79. C.R. McCurdy, K.J. Sufka, G.H. Smith, J.E. Warnick, and M.J. Nieto Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist Pharmacol. Biochem. Behav. 83 2006 109 113
80. J.E. Mendelson, J.R. Coyle, J.C. Lopez, M.J. Baggott, K. Flower, E.T. Everhart, T.A. Munro, G.P. Galloway, and B.M. Cohen Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial Psychopharmacology 2011 1 7
81. Mexico Map [WWW Document], n.d. URL ahttp://www.mapsopensource.com/ mexico.htmla (accessed 9.24.13).
82. R. Misra, R.C. Pandey, and S. Dev The absolute stereochemistry of hardwickiic acid and its congeners Tetrahedron Lett. 9 1968 2681 2684
83. J. Mooney Mixe Indians 1911 Robert Appleton Company New York
84. A.S. Morani, B. Kivell, T.E. Prisinzano, and S. Schenk Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats Pharmacol. Biochem. Behav. 94 2009 244 249
85. M. Mowry, M. Mosher, and W. Briner Acute physiologic and chronic histologic changes in rats and mice exposed to the unique hallucinogen salvinorin A J. Psychoact. Drugs 35 2003 379 382
86. Munro, T.A.; 2006. The Chemistry of Salvia divinorum.
87. T.A. Munro, and M.A. Rizzacasa Salvinorins DF, new neoclerodane diterpenoids from Salvia divinorum, and an improved method for the isolation of salvinorin A J. Nat. Prod. 66 2003 703 705
88. T.M. Murphy, and G. Bola DNA identification of Salvia divinorum samples Forensic Sci. Int. Genet. 7 2013 189 193
89. J. Ogata, N. Uchiyama, R. Kikura-Hanajiri, and Y. Goda DNA Sequence Analyses of Blended Herbal Products Including Synthetic Cannabinoids as Designer Drugs 2012 Forensic Science International
90. A.L. Okunade, and D.F. Wiemer (-)-Loliolide, an ant-repellent compound from Xanthoxyllum setulosum J. Nat. Prod. 48 1985 472 473
91. R.G. Olmstead, B. Bremer, K.M. Scott, and J.D. Palmer A parsimony analysis of the Asteridae sensu lato based on rbcL sequences Ann. Missouri Bot. Garden 1993 700 722
92. A. Ortega, J.F. Blount, and P.S. Manchand Salvinorin, a new trans-neoclerodane diterpene from Salvia divinorum (Labiatae) J. Chem. Soc. Perkins Trans. 1 1982 2505 2508
93. J. Ott Pharmacotheon: Entheogenic Drugs, Their Plant Sources and History 1993 Natural Products Co
94. J. Ott Ethnopharmacognosy and human pharmacology of Salvia divinorum and salvinorin A Curare 18 1995 103 129
95. J. Ott Psychoactive card IV Eleusis 4 1996 31 39
96. I.C. Paul, G.A. Sim, T.A. Hamor, and J.M. Robertson The structure of clerodin: X-ray analysis of clerodin bromo-lactone J. Chem. Soc. 1962 4133 4145
97. R.G. Pertwee The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9tetrahydrocannabinol, cannabidiol and Δ9tetrahydrocannabivarin Br. J. Pharmacol. 153 2008 199 215
98. S.M. Phipps, and V. Butterweck A new digitized method of the compulsive gnawing test revealed dopaminergic activity of salvinorin A - in vivo Planta Med. 76 2010 1405 1410
99. S. Pichini, S. Abanades, M. Farré, M. Pellegrini, E. Marchei, R. Pacifici, R. Torre, and P. Zuccaro Quantification of the plantderived hallucinogen salvinorin A in conventional and nonconventional biological fluids by gas chromatography/mass spectrometry after Salvia divinorum smoking Rapid Commun. Mass Spectrom. 19 2005 1649 1656
100. G. Pompa Salvia divinorum Herbarium Sheets: 87556 & 93216 1957 Mexican National Herbarium (UNAM) Mexico City
101. T.E. Prisinzano Psychopharmacology of the hallucinogenic sage Salvia divinorum Life Sci. 78 2005 527 531
102. T.E. Prisinzano Neoclerodanes as atypical opioid receptor ligands J. Med. Chem. 56 2013 3435 3443
103. T.E. Prisinzano, and R.B. Rothman Salvinorin A analogs as probes in opioid pharmacology Chem. Rev. 108 2008 1732 1743
104. M.S. Rajab, C.L. Cantrell, S.G. Franzblau, and N.H. Fischer Antimycobacterial activity of (E)-phytol and derivatives: a preliminary structure-activity study Planta Med. Nat. Prod. Med. Plant Res. 64 1998 2 4
105. M.S. Rajab, C.L. Cantrell, S.G. Franzblau, and N.H. Fischer Antimycobacterial activity of (E)-phytol and derivatives: a preliminary structure-activity study Planta Med. Nat. Prod. Med. Plant Res. 64 1998 2 4
106. M. Ranganathan, A. Schnakenberg, P.D. Skosnik, B.M. Cohen, B. Pittman, R.A. Sewell, and D.C. D'Souza Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist salvinorin A in humans Biol. Psychiatry 2012
107. N.U. Reddy Molecular phylogeny of angiospermic plant families using RBCL gene sequences Int. J. Bioinf. Res. 1 2009 27 36
108. A.S. Reisfield The botany of Salvia divinorum (Labiatae) SIDA 15 1993 349 366
109. B.L. Roth, K. Baner, R. Westkaemper, D. Siebert, K.C. Rice, S.A. Steinberg, P. Ernsberger, and R.B. Rothman Salvinorin A: a potent naturally occurring nonnitrogenous κ opioid selective agonist Proc. Nat. Acad. Sci. 99 2002 11934
110. M.S. Schmidt, T.E. Prisinzano, K. Tidgewell, W. Harding, E.R. Butelman, M.J. Kreek, and D.J. Murry Determination of Salvinorin A in body fluids by high performance liquid chromatography-atmospheric pressure chemical ionization J. Chromatogr. B 818 2005 221 225
111. Schmidt, M.S. Schmidt, E.R. Butelman, W.W. Harding, K. Tidgewell, D.J. Murry, M.J. Kreek, and T.E. Prisinzano Pharmacokinetics of the plantderived κopioid hallucinogen salvinorin A in nonhuman primates Synapse 58 2005 208 210
112. Schühly, W.; Fabian, C.; Jahangir, S.; Fabian, W.; 2007. Structure and Absolute Configuration of Loliolide Isomers Determined by Comparison of Calculated and Experimental CD Spectra. Presented at the International Electronic Conference on Synthetic Organic Chemistry.
113. Schultes, 1967. The place of ethnobotany in the ethnpharmacologic search for psychotomimetic drugs. In:, D.H.E. et al. (Eds.), Ethnpharmacologic Search for Psychotomimetic Drugs. US Government Printing Office, pp. 37-57.
114. Schultes Hallucinogens of plant origin Science 163 1969 245 254
115. Schultes The botanical and chemical distribution of hallucinogens Annu. Rev. Plant Physiol. 21 1970 571 598
116. Schultes An overview of hallucinogens in the Western Hemisphere P.T. Furst, Flesh of the Gods: The Ritual Use of Hallucinogens 1972 3 54
117. Schultes Hallucinogenic Plants, A Golden Guide 1976 Golden Press
118. Schultes, A. Hofmann, and C. Rätsch Plants of the Gods - Their Sacred, Healing, and Hallucinogenic Powers 2001 Healing Arts Press Rochester
119. C. Schwarzer 30 Years of dynorphins - new insights on their functions in neuropsychiatric diseases Pharmacol. Ther. 123 2009 353 370
120. D.J. Sheffler, and B.L. Roth Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor Trends Pharmacol. Sci. 24 2003 107 109
121. O. Shirota, K. Nagamatsu, and S. Sekita Neo-clerodane diterpenes from the hallucinogenic sage Salvia divinorum J. Nat. Prod. 69 2006 1782 1786
122. Siebert Salvia divinorum and salvinorin A: new pharmacologic findings J. Ethnopharmacol. 43 1994 53 56
123. Siebert The History of the first Salvia divinorum plants cultivated outside of Mexico Etheogen Rev. XII 2003 117 118
124. Siebert Localization of salvinorin A and related compounds in glandular trichomes of the psychoactive sage, Salvia divinorum Ann. Botany 93 2004 763 771
125. Kenneth J. Sufka, Melissa J. Loria, Kevin Lewellyn, Jordan K. Zjawiony, Zulfiqar Ali, Naohito Abe, and Ikhlas A. Khan The effect of Salvia divinorum and Mitragyna speciosa extracts, fraction and major constituents on place aversion and place preference in rats J. Ethnopharmacol. 2013 (In Press) ahttps://www.sciencedirect.com/science/article/pii/S0378874113007848a
126. Z.S. Teksin, I.J. Lee, N.N. Nemieboka, A.A. Othman, V.V. Upreti, H.E. Hassan, S.S. Syed, T.E. Prisinzano, and N.D. Eddington Evaluation of the transport, in vitro metabolism and pharmacokinetics of salvinorin A, a potent hallucinogen Eur. J. Pharm. Biopharm. 72 2009 471 477
127. K. Tsujikawa, K. Kuwayama, H. Miyaguchi, T. Kanamori, Y.T. Iwata, and H. Inoue In vitro stability and metabolism of salvinorin A in rat plasma Xenobiotica 39 2009 391 398
128. L.J. Valdés Loliolide from Salvia divinorum J. Nat. Prod. 49 1986 171 (171)
129. L.J. Valdés Salvia divinorum and the unique diterpene hallucinogen, salvinorin (divinorin) A J. Psychoact. Drugs 1994
130. L.J. Valdés The early history of Salvia divinorum Entheogen Rev. 10 2001 73 75
131. L.J. Valdés, W.M. Butler, G.M. Hatfield, A.G. Paul, and M. Koreeda Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum J. Org. Chem. 49 1984 4716 4720
132. L.J. Valdés, H.-M. Chang, D.C. Visger, and M. Koreeda Salvinorin C, a new neoclerodane diterpene from a bioactive fraction of the hallucinogenic Mexican mint Salvia divinorum Org. Lett. 3 2001 3935 3937
133. L.J. Valdés, H.M. Chang, D.C. Visger, and M. Koreeda ChemInform abstract: salvinorin C, a new neoclerodane diterpene from a bioactive fraction of the hallucinogenic Mexican mint Salvia divinorum ChemInform 33 2002 (no-no)
134. L.J. Valdés, J.L. Diaz, and A.G. Paul Ethnopharmacology of ska maria pastora (Salvia divinorum, Epling and Játiva-M.) J. Ethnopharmacol. 7 1983 287 312
135. L.J. Valdés, G. Hatheld, M. Koreeda, and A. Paul Studies of Salvia divinorum (Lamiaceae), an hallucinogenic mint from the Sierra Mazateca in Oaxaca, Central Mexico Econ. Bot. 41 1987 283 291
136. R. Vohra, A. Seefeld, F.L. Cantrell, and R.F. Clark Salvia divinorum: exposures reported to a statewide poison control system over 10 years J. Emerg. Med. 40 2011 643 650
137. T.A. Vortherms, and B.L. Roth Salvinorin A: from natural product to human therapeutics Mol. Interventions 6 2006 257
138. S.J. Wagstaff, L. Hickerson, R. Spangler, P. Reeves, and R. Olmstead Phylogeny in Labiatae inferred from cpDNA sequences Plant Syst. Evol. 209 1998 265 274
139. Sytsma Walker, K. Treutlein, and J. Wink, M. Salvia (Lamiaceae) is not monophyletic: implications for the systematics, radiation, and ecological specializations of Salvia and tribe Menthaea Am. J. Bot. 91 2004 1115 1125
140. Walker, and K.J. Sytsma Staminal evolution in the genus Salvia (Lamiaceae): molecular phylogenetic evidence for multiple origins of the staminal lever Ann. Botany 100 2007 375
141. Sytsma Walker, K.J. Treutlein, and J. Wink, M. Salvia (Lamiaceae) is not monophyletic: implications for the systematics, radiation, and ecological specializations of Salvia and tribe Mentheae Am. J. Bot. 91 2004 1115 1125
142. Wasson, R.G.; 1962. A New Psychotropic Drug from the Mint Family. Botanical Museum Leaflets, Harvard University 20.
143. R.J. Weitlander Curaciones Mazatecas Anales del Instituto Nacional de Antropologia e Historica 4 1952 279 285
144. C.B. Willmore-Fordham, D.M. Krall, C.R. McCurdy, and D.H. Kinder The hallucinogen derived from Salvia divinorum, salvinorin A, has κ-opioid agonist discriminative stimulus effects in rats Neuropharmacology 53 2007 481 486
145. J.R.I. Wood, and R.M. Harley The genus Salvia (Labiatae) in Colombia Kew Bull. 1989 211 278
146. www.salviasource.org, 2011. Salvia divinorum Seeds Have Set [WWW Document]. URL ahttp://www.salviasource.org/forum/index.php?topic=876a (accessed 1.16.12).
147. F. Yan, P.D. Mosier, R.B. Westkaemper, J. Stewart, J.K. Zjawiony, T.A. Vortherms, D.J. Sheffler, and B.L. Roth Identification of the molecular mechanisms by which the diterpenoid salvinorin A binds to κ-opioid receptors Biochemistry 44 2005 8643 8651
148. J.B. Zawilska, and J. Wojcieszak Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug Hum. Psychopharmacol.: Clin. Exp 2013
149. Y. Zhang, E.R. Butelman, S.D. Schlussman, A. Ho, and M.J. Kreek Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors Psychopharmacology 179 2005 551 558